The epidemiology and impact of migraine

被引:80
作者
Bigal M.E. [1 ]
Lipton R.B. [1 ]
Stewart W.F. [1 ]
机构
[1] Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461
关键词
Migraine; Sumatriptan; Migraine With Aura; Headache Disorder; Rizatriptan;
D O I
10.1007/s11910-004-0022-8
中图分类号
学科分类号
摘要
Migraine is a highly prevalent headache disorder that has a substantial impact on the individual and society. In this article, we review the burden of migraine, emphasizing the population-based studies that used standardized diagnostic criteria. We highlight descriptive epidemiology, burden of disease, patterns of diagnosis, and treatment. We focus on the epidemiology and burden of probable migraine, a subtype of migraine where just one clinical feature is missing. We finish by describing approaches to improving healthcare delivery for migraine and probable migraine. Although migraine is a remarkably common cause of temporary disability, many migraineurs, even those with disabling headache, have never consulted a physician for the problem. Prevalence is highest in women, in persons between the ages of 25 and 55 years, and, at least in the United States, in individuals from low-income households. Nonetheless, prevalence is high in groups other than these high-risk groups. Probable migraine is a prevalent form of migraine, and like migraine with and without aura it produces decrements in health-related quality of life and increments in disability relative to control subjects. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:98 / 104
页数:6
相关论文
共 49 条
[1]  
Linet M.S., Celentano D.D., Stewart W.F., Headache characteristics associated with physician consultation: A population-based survey, Am. J. Prev. Med., 7, pp. 40-46, (1991)
[2]  
Pascual J., Combarros O., Leno C., Et al., Distribution of headache by diagnosis as the reason for neurologic consultation, Med. Clin., 104, pp. 161-164, (1995)
[3]  
Scher A.I., Stewart W.F., Lipton R.B., Migraine and headache: A meta-analytic approach, Epidemiology of Pain, 1999, pp. 159-170
[4]  
Rasmussen B.K., Epidemiology of headache, Cephalalgia, 15, pp. 45-68, (1995)
[5]  
Lipton R.B., Amatniek J.C., Ferrari M.D., Et al., Migraine: Identifying and removing barriers to care, Neurology, 44, SUPPL. 6, pp. 56-62, (1994)
[6]  
Headache classification committee of the international Headache Society: The International Classification of Headache Disorders, Cephalalgia, 24, SUPPL. 1, pp. 1-160, (2004)
[7]  
Lipton R.B., Stewart W.F., Simon D., Medical consultation for migraine: Results from the American Migraine Study, Headache, 38, pp. 91-96, (1998)
[8]  
Lipton R.B., Diamond S., Reed M., Et al., Migraine diagnosis and treatment: Results from the American Migraine Study II, Headache, 41, pp. 638-645, (2001)
[9]  
Lipton R.B., Stewart W.F., Diamond S., Et al., Prevalence and burden of migraine in the United States: Data from the American Migraine Study II, Headache, 41, pp. 646-657, (2001)
[10]  
Waters W.E., Headache (Series in Clinical Epidemiology), (1986)